Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Keyphrases

• Atrophy 20%
• Biomarker Changes 100%
• Biomarker Progressions 20%
• C9orf72 mutation 20%
• Clinical Change 100%
• Clinical Measures 20%
• Clinical Progression 20%
• Clinical Score 20%
• Clinical Simulation 20%
• Clinical Trials 40%
• Dementia Diseases 20%
• Dementia Prevention 20%
• Disease Prevention 20%
• Disease Progression 20%
• Disease Progression Modeling 20%
• Enrollment Criteria 20%
• Familial Alzheimer's Disease 20%
• Frontotemporal Dementia 100%
• Genotype 20%
• GRN mutation 20%
• International Recruitment 20%
• MAPT mutation 20%
• Multimodal Model 20%
• Mutation Carriers 40%
• Neurofilament Light (NF-L) 20%
• Neuropsychological Tests 20%
• Non-carriers 20%
• Patient Selection 20%
• Plasma Neurofilament Light Chain 20%
• Prevention Trials 60%
• Regional Brain Volumes 20%
• Symptom Onset 20%
• Temporal Order 100%
• Treatment Effect 20%
• Trial Sample Size 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Alzheimer's Disease 20%
• Biological Marker 100%
• Clinical Trial 40%
• Disease 20%
• Disease Exacerbation 40%
• Frontotemporal Dementia 100%

Neuroscience

• Blood Plasma 20%
• Familial Alzheimer's Disease 20%
• Frontotemporal Dementia 100%
• Neurofilament Light Chain 40%